Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Yosprala Approval

<< Previous

Bullboard Posts

Next >>

Comment by kuatoliveson Aug 09, 2016 1:36pm

88 Views

Post# 25123251

RE:RE:RE:RE:Yosprala Approval

I'm glad they're not on the hunt for some new acquisition but rather focusing on their core business, at least unless some golden goose comes along. The last thing shareholders need is some boneheaded acquisition that piles on the debt and annoys investors just so they can increase the bottom line - which Valeant, CXR, Merus etc, have shown produces limited, if any, long term shareholder value. Maybe we'll get yosprala approval this month so they can produce Q4 numbers with that drug on the sheet.

<< Previous

Bullboard Posts

Next >>

Arbor Metals unearths encouraging results in lithium exploration